Related Experiment Videos

Meningeal tumors of infancy and childhood

Pediatric Pathology
|January 1, 1985
PubMed

Insights

Electron microscopy and immunohistochemistry aid in diagnosing challenging childhood meningeal tumors. These techniques, using markers like S-100 protein and muramidase, improve diagnostic accuracy for various tumor types.

Area of Science:

  • Neuropathology
  • Pediatric Oncology
  • Diagnostic Pathology

Background:

  • Childhood meningeal tumors present diagnostic challenges due to morphological variability.
  • Accurate histopathological classification is crucial for predicting clinical outcomes.
  • Advanced diagnostic tools are needed to differentiate between benign and malignant meningeal lesions in children.

Observation:

  • Seventeen meningeal tumors (meningiomas, hemangiopericytoma, meningeal sarcomas, fibrous histiocytomas, malignant melanomas) were analyzed.
  • Electron microscopy and immunohistochemistry (GFAP, S-100, muramidase, Factor VIII) were employed.
  • Clinical outcomes varied, with some benign-appearing meningiomas showing poor prognosis and aggressive-appearing fibrous histiocytomas having good outcomes.

Findings:

  • S-100 protein was detected in two meningiomas with poor outcomes.
  • Muramidase served as a useful marker for certain meningeal tumors.
  • Meningeal sarcomas, including myxofibrosarcomas, exhibited rapid clinical decline.
  • Fibrous histiocytomas, despite aggressive histology, had favorable outcomes.

Implications:

  • Electron microscopy and immunohistochemistry are valuable adjuncts for diagnosing pediatric meningeal tumors.
  • These techniques can help resolve morphological ambiguities and improve diagnostic precision.
  • Enhanced diagnostic capabilities may lead to better-tailored treatment strategies and prognostic assessments for affected children.

Related Concept Videos